Almut Schulze

32PUBLICATIONS
219CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMolecular targetsMedical biochemistry - inorganic elements and compoundsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 10, 2026
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescence.

|Apr 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Feb 27, 2026
Activation of IRF3 in cardiomyocytes impairs mitochondrial oxidative function through PGC-1α inhibition and drives heart failure.

Manju Kumari, Ioannis Evangelakos, Anushka Deshpande

|Feb 04, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki

|Jan 21, 2026
Publisher Correction: Multiple oestradiol functions inhibit ferroptosis and acute kidney injury.

Wulf Tonnus, Francesca Maremonti, Shubhangi Gavali

Pageof 6

Frequent Collaborators

7 joint publications

Lisa Schlicker

5 joint publications

Marteinn T Snaebjornsson

5 joint publications

Werner Schmitz

3 joint publications

Felix C E Vogel